FTI vs. AXSM
FTI (TechnipFMC plc) and AXSM (Axsome Therapeutics, Inc.) are both stocks. FTI operates in Oil & Gas Equipment & Services (Energy), while AXSM operates in Biotechnology (Healthcare). Over the past 10 years, FTI returned 13.30%/yr vs 44.83%/yr for AXSM. At a 0.17 correlation, their price movements are largely independent.
Performance
FTI vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FTI achieves a 46.47% return, which is significantly higher than AXSM's 37.16% return. Over the past 10 years, FTI has underperformed AXSM with an annualized return of 13.30%, while AXSM has yielded a comparatively higher 44.83% annualized return.
FTI
- 1D
- -2.75%
- 1M
- -8.20%
- YTD
- 46.47%
- 6M
- 45.94%
- 1Y
- 86.16%
- 3Y*
- 65.31%
- 5Y*
- 50.06%
- 10Y*
- 13.30%
AXSM
- 1D
- -0.66%
- 1M
- 6.16%
- YTD
- 37.16%
- 6M
- 64.10%
- 1Y
- 148.78%
- 3Y*
- 43.37%
- 5Y*
- 30.05%
- 10Y*
- 44.83%
FTI vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FTI TechnipFMC plc | 46.47% | 54.90% | 44.78% | 66.07% | 105.91% | -15.36% | -55.23% | 12.09% | -36.32% | -11.44% |
AXSM Axsome Therapeutics, Inc. | 37.16% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
Correlation
The correlation between FTI and AXSM is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2015 | 0.17 |
The correlation between FTI and AXSM shifts across timeframes, from -0.03 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.
Fundamentals
FTI:
$26.71B
AXSM:
$12.83B
FTI:
$2.59
AXSM:
-$3.74
FTI:
2.67
AXSM:
17.80
FTI:
7.94
AXSM:
234.95
FTI:
$10.19B
AXSM:
$708.24M
FTI:
$2.75B
AXSM:
$655.82M
FTI:
$1.13B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTI vs. AXSM — Risk / Return Rank
FTI
AXSM
FTI vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TechnipFMC plc (FTI) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FTI | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.78 | ||
| Sortino ratioReturn per unit of downside risk | -1.36 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.58 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 5.60 | 7.80 | -2.20 |
| Martin ratioReturn relative to average drawdown | 16.87 | 22.99 | -6.12 |
Loading charts...
Drawdowns
FTI vs. AXSM - Drawdown Comparison
The maximum FTI drawdown since its inception was -91.74%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for FTI and AXSM.
Loading charts...
Drawdown Indicators
| FTI | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.74% | -86.65% | -5.09% |
Max Drawdown (1Y)Largest decline over 1 year | -15.29% | -18.50% | +3.21% |
Max Drawdown (3Y)Largest decline over 3 years | -28.94% | -34.83% | +5.89% |
Max Drawdown (5Y)Largest decline over 5 years | -41.32% | -72.91% | +31.59% |
Max Drawdown (10Y)Largest decline over 10 years | -85.71% | -81.26% | -4.45% |
Current DrawdownCurrent decline from peak | -15.29% | -1.83% | -13.46% |
Average DrawdownAverage peak-to-trough decline | -33.90% | -39.42% | +5.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.08% | 6.27% | -1.19% |
Volatility
FTI vs. AXSM - Volatility Comparison
TechnipFMC plc (FTI) has a higher volatility of 9.82% compared to Axsome Therapeutics, Inc. (AXSM) at 8.89%. This indicates that FTI's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FTI | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.82% | 8.89% | +0.93% |
Volatility (6M)Calculated over the trailing 6-month period | 21.99% | 33.12% | -11.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.91% | 41.72% | -9.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.42% | 70.26% | -27.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.72% | 90.42% | -42.70% |
Dividends
FTI vs. AXSM - Dividend Comparison
FTI's dividend yield for the trailing twelve months is around 0.31%, while AXSM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FTI TechnipFMC plc | 0.31% | 0.45% | 0.69% | 0.50% | 0.00% | 0.00% | 1.38% | 2.43% | 2.66% | 0.42% |
Financials
FTI vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between TechnipFMC plc and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
FTI vs. AXSM - Profitability Comparison
FTI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TechnipFMC plc reported a gross profit of 1.49B and revenue of 2.49B. Therefore, the gross margin over that period was 59.7%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
FTI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TechnipFMC plc reported an operating income of 351.00M and revenue of 2.49B, resulting in an operating margin of 14.1%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
FTI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TechnipFMC plc reported a net income of 260.50M and revenue of 2.49B, resulting in a net margin of 10.5%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
Frequently Asked Questions
FTI and AXSM have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FTI has higher volatility (9.82%) compared to AXSM (8.89%). In terms of maximum drawdown, FTI dropped -91.74% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (3.46 vs 2.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FTI and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer